BetaEntity Annotation Prototype

Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed

All extracted diseases

Showing 61–120 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.

Articles mentioning diseases

23,712 articles · page 304 of 1976
atrial fibrillationHFpEFAFHFmrEFempagliflozindapagliflozinSGLT2iClinicalTrials.govSGLT2 inhibitors

…nd cardiovascular death in patients with HFpEF/HFmrEF. However, atrial fibrillation (AF) is highly prevalent in this population. While post-hoc ana…

acute coronary syndromesIn-Stent Restenosismultivessel diseasebifurcation diseaseheavily calcified lesionsNational Institute for Cardiovascular Outcomes ResearchDrug-Coated Balloon therapypotent antithromboticsNICOR

…ase), the increasing prescription of potent P2Y12 inhibitors in acute coronary syndromes, and the rapid diffusion of Drug-Coated Balloon therapy for In-…

systemic sclerosisCOVID-19pulmonary arterial hypertensionidiopathic pulmonary arterial hypertensionEur Heart J Cardiovasc ImagingAm J Physiol Heart Circ PhysiolJ Cardiovasc Magn ResonCirc Cardiovasc Imaging

…lmonary arterial hypertension; ToF = Tetralogy of Fallot; SSc = systemic sclerosis; IPAH = idiopathic pulmonary arterial hypertension; CTEPH = chr…

197 Improving genetic testing pathways in idiopathic pulmonary arterial hypertension

heartjnl · abstract · 2026-06-09 · 8 matching annotations

95.6%
pulmonary arterial hypertensionpulmonary hypertensionPulmonary hypertension (PH)pulmonary capillary haemangiomatosispulmonary veno-occlusive diseasepulmonary arterial hypertension (PAH)congenital heart diseaseIPAHhydroxychloroquinephenylbutyrate

…e II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2. Trials. 2024;25(1):680.Abstract 1…